{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:39:51Z","timestamp":1793572791188,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71890-6","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:03:25Z","timestamp":1725969805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Increased oxidative stress biomarkers in central serous chorioretinopathy"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7929-5571","authenticated-orcid":false,"given":"Esra","family":"Er\u00e7in Ak\u0131dan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9780-2437","authenticated-orcid":false,"given":"Esin","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3865-9156","authenticated-orcid":false,"given":"Necat","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1395-3519","authenticated-orcid":false,"given":"Melih","family":"Ak\u0131dan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"71890_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.4103\/ijo.IJO_2152_19","volume":"68","author":"A Mohan","year":"2020","unstructured":"Mohan, A. et al. Commentary: Our understanding of central serous chorioretinopathy-coming a full circle?. Indian J. Ophthalmol. 68, 858\u2013859. https:\/\/doi.org\/10.4103\/ijo.IJO_2152_19 (2020).","journal-title":"Indian J. Ophthalmol."},{"key":"71890_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.27965","volume":"14","author":"J Varghese","year":"2022","unstructured":"Varghese, J. et al. A review of central serous chorioretinopathy: Clinical presentation and management. Cureus 14, 1\u20136. https:\/\/doi.org\/10.7759\/cureus.27965 (2022).","journal-title":"Cureus"},{"key":"71890_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/ceo.14201","volume":"51","author":"AT Fung","year":"2023","unstructured":"Fung, A. T. et al. Central serous chorioretinopathy: A review. Clin. Exp. Ophthalmol. 51, 243\u2013270. https:\/\/doi.org\/10.1111\/ceo.14201 (2023).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"71890_CR4","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41433-021-01808-3","volume":"36","author":"P Kanda","year":"2022","unstructured":"Kanda, P. et al. Pathophysiology of central serous chorioretinopathy: A literature review with quality assessment. Eye (Lond.) 36, 941\u2013962. https:\/\/doi.org\/10.1038\/s41433-021-01808-3 (2022).","journal-title":"Eye (Lond.)"},{"key":"71890_CR5","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","volume":"73","author":"TJ Rijssen","year":"2019","unstructured":"Rijssen, T. J. et al. Central serous chorioretinopathy: Towards an evidence-based treatment guideline. Prog. Retin. Eye Res. 73, 100770. https:\/\/doi.org\/10.1016\/j.preteyeres.2019.07.003 (2019).","journal-title":"Prog. Retin. Eye Res."},{"key":"71890_CR6","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/s1043-2760(01)00538-0","volume":"13","author":"AM Capponi","year":"2002","unstructured":"Capponi, A. M. Regulation of cholesterol supply for mineralocorticoid biosynthesis. Trends Endocrinol. Metab. 13, 118\u2013121. https:\/\/doi.org\/10.1016\/s1043-2760(01)00538-0 (2002).","journal-title":"Trends Endocrinol. Metab."},{"key":"71890_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2022.938600","volume":"9","author":"N Hashida","year":"2022","unstructured":"Hashida, N. et al. Mitochondrial DNA as a biomarker for acute central serous chorioretinopathy: A case-control study. Front. Med. (Lausanne) 9, 1\u201310. https:\/\/doi.org\/10.3389\/fmed.2022.938600 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"71890_CR8","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s00417-020-04664-1","volume":"258","author":"H Kunikata","year":"2020","unstructured":"Kunikata, H. et al. Systemic oxidative stress level in patients with central serous chorioretinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 258, 1575\u20131577. https:\/\/doi.org\/10.1007\/s00417-020-04664-1 (2020).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"71890_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/ijo.IJO_3168_20","volume":"69","author":"M Jain","year":"2021","unstructured":"Jain, M. et al. Comments on: Monocyte to high-density lipoprotein ratio in central serous chorioretinopathy: A biomarker of inflammation or epiphenomenon. Indian J. Ophthalmol. 69, 471. https:\/\/doi.org\/10.4103\/ijo.IJO_3168_20 (2021).","journal-title":"Indian J. Ophthalmol."},{"key":"71890_CR10","doi-asserted-by":"publisher","first-page":"854","DOI":"10.4103\/ijo.ijo_1327_19","volume":"68","author":"E Sirakaya","year":"2020","unstructured":"Sirakaya, E. et al. Monocyte to high-density lipoprotein and neutrophil-to-lymphocyte ratios in patients with acute central serous chorioretinopathy. Indian J. Ophthalmol. 68, 854\u2013858. https:\/\/doi.org\/10.4103\/ijo.ijo_1327_19 (2020).","journal-title":"Indian J. Ophthalmol."},{"key":"71890_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/aos.15263","volume":"101","author":"EHC van Dijk","year":"2022","unstructured":"van Dijk, E. H. C. et al. Comparative efficacy of treatments for chronic central serous chorioretinopathy: A systematic review with network meta-analyses. Acta Ophthalmol. 101, 140\u2013159. https:\/\/doi.org\/10.1111\/aos.15263 (2022).","journal-title":"Acta Ophthalmol."},{"key":"71890_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/bjophthalmol-2013-303945","volume":"98","author":"SN Chen","year":"2014","unstructured":"Chen, S. N. et al. Increased risk of coronary heart disease in male patients with central serous chorioretinopathy: Results of a population-based cohort study. Br. J. Ophthalmol. 98, 110\u2013114. https:\/\/doi.org\/10.1136\/bjophthalmol-2013-303945 (2014).","journal-title":"Br. J. Ophthalmol."},{"key":"71890_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/25158414231168813","volume":"15","author":"E Atalay","year":"2023","unstructured":"Atalay, E. et al. The role of oxidative damage in cataract etiopathogenesis. Ther. Adv. Ophthalmol. 15, 1\u20138. https:\/\/doi.org\/10.1177\/25158414231168813 (2023).","journal-title":"Ther. Adv. Ophthalmol."},{"key":"71890_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/02713683.2013.774023","volume":"38","author":"N U\u011furlu","year":"2013","unstructured":"U\u011furlu, N. et al. Oxidative stress and anti-oxidative defence in patients with age-related macular degeneration. Curr. Eye Res. 38, 497\u2013502. https:\/\/doi.org\/10.3109\/02713683.2013.774023 (2013).","journal-title":"Curr. Eye Res."},{"key":"71890_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3164\/jcbn.11-00020R1","volume":"51","author":"H Itabe","year":"2012","unstructured":"Itabe, H. Oxidize low-density lipoprotein as a biomarker of in vivo oxidative stres: From atherosclerosis to periodontitis. J. Clin. Biochem. Nutr. 51, 1\u20138. https:\/\/doi.org\/10.3164\/jcbn.11-00020R1 (2012).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"71890_CR16","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1002\/mnfr.201000190","volume":"10","author":"C Boesch-Saadatmandi","year":"2010","unstructured":"Boesch-Saadatmandi, C. et al. Determinants of paraoxonase activity in healthy adults. Mol. Nutr. Food Res. 10, 1842\u20131850. https:\/\/doi.org\/10.1002\/mnfr.201000190 (2010).","journal-title":"Mol. Nutr. Food Res."},{"key":"71890_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10238-009-0084-7","volume":"10","author":"M Nowak","year":"2010","unstructured":"Nowak, M. et al. Antioxidant potential, paraoxonase 1, ceruplasmin activity and C-reactive protein concentration in diabetic retinopathy. Clin. Exp. Med. 10, 185\u2013192. https:\/\/doi.org\/10.1007\/s10238-009-0084-7 (2010).","journal-title":"Clin. Exp. Med."},{"key":"71890_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.31348\/2023\/27","volume":"80","author":"K Mysl\u00edk Manethov\u00e1","year":"2024","unstructured":"Mysl\u00edk Manethov\u00e1, K. Central serous chorioretinopathy. a review. Cesk Slov Oftalmol. 80, 59\u201375. https:\/\/doi.org\/10.31348\/2023\/27 (2024).","journal-title":"Cesk Slov Oftalmol."},{"key":"71890_CR19","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/15321819.2020.1726774","volume":"41","author":"A Ahmad","year":"2020","unstructured":"Ahmad, A. et al. Biomarkers of inflammation and oxidative stress in ophthalmic disorders. J. Immunoass. Immunochem. 41, 257\u2013271. https:\/\/doi.org\/10.1080\/15321819.2020.1726774 (2020).","journal-title":"J. Immunoass. Immunochem."},{"key":"71890_CR20","unstructured":"Gupta, A. et al. Central serous chorioretinopathy. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. PMID: 32644399. http:\/\/www.ncbi.nlm.nih.gov\/books\/nbk558973\/ (2024)."},{"key":"71890_CR21","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4103\/2211-5056.362601","volume":"12","author":"M Jain","year":"2022","unstructured":"Jain, M. et al. Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification. Taiwan J. Ophthalmol. 12, 381\u2013393. https:\/\/doi.org\/10.4103\/2211-5056.362601 (2022).","journal-title":"Taiwan J. Ophthalmol."},{"key":"71890_CR22","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.2174\/1381612825666190115121531","volume":"24","author":"O Tangvarasittichai","year":"2018","unstructured":"Tangvarasittichai, O. et al. Oxidative stress, ocular disease and diabetes retinopathy. Curr. Pharm. Des. 24, 4726\u20134741. https:\/\/doi.org\/10.2174\/1381612825666190115121531 (2018).","journal-title":"Curr. Pharm. Des."},{"key":"71890_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.7754\/clin.lab.2013.121229","volume":"60","author":"BC Demird\u00f6gen","year":"2014","unstructured":"Demird\u00f6gen, B. C. et al. Evaluation of oxidative stress and paraoxonase phenotypes in pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Clin. Lab. 60, 79\u201386. https:\/\/doi.org\/10.7754\/clin.lab.2013.121229 (2014).","journal-title":"Clin. Lab."},{"key":"71890_CR24","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.freeradbiomed.2009.01.012","volume":"46","author":"Z Hashim","year":"2009","unstructured":"Hashim, Z. et al. Expression and activity of paraoxonase 1 in human cataractous lens tissue. Free Radic. Biol. Med. 46, 1089\u20131095. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.01.012 (2009).","journal-title":"Free Radic. Biol. Med."},{"key":"71890_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.redox.2015.01.002","volume":"4","author":"H Sies","year":"2015","unstructured":"Sies, H. Oxidative stress: A concept in redox biology and medicine. Redox Biol. 4, 180\u2013183. https:\/\/doi.org\/10.1016\/j.redox.2015.01.002 (2015).","journal-title":"Redox Biol."},{"key":"71890_CR26","first-page":"722","volume":"26","author":"A Daruich","year":"2020","unstructured":"Daruich, A. et al. Levels of the oxidative stress biomarker malondialdehyde in tears of patients with central serous chorioretinopathy relate to disease activity. Mol. Vis. 26, 722\u2013730 (2020).","journal-title":"Mol. Vis."},{"key":"71890_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/njcp.njcp_378_19","volume":"24","author":"S Urfalioglu","year":"2021","unstructured":"Urfalioglu, S. et al. Oxidative stress parameters and antioxidant enzyme levels in patients with central serous chorioretinopathy. Niger. J. Clin. Pract. 24, 64\u201368. https:\/\/doi.org\/10.4103\/njcp.njcp_378_19 (2021).","journal-title":"Niger. J. Clin. Pract."},{"key":"71890_CR28","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.3109\/02713683.2015.1127390","volume":"41","author":"EB Turkoglu","year":"2016","unstructured":"Turkoglu, E. B. et al. Thiol\/disulfide homeostasis in patients with central serous chorioretinopathy. Curr. Eye Res. 41, 1489\u20131491. https:\/\/doi.org\/10.3109\/02713683.2015.1127390 (2016).","journal-title":"Curr. Eye Res."},{"key":"71890_CR29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10792-017-0444-3","volume":"38","author":"H Altinkaynak","year":"2018","unstructured":"Altinkaynak, H. et al. A novel marker in acute central serous chorioretinopathy: thiol\/disulfide homeostasis. Int. Ophthalmol. 38, 175\u2013181. https:\/\/doi.org\/10.1007\/s10792-017-0444-3 (2018).","journal-title":"Int. Ophthalmol."},{"key":"71890_CR30","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00417-013-2396-2","volume":"252","author":"FM T\u00fcrkc\u00fc","year":"2014","unstructured":"T\u00fcrkc\u00fc, F. M. et al. Serum dehydroepiandrosterone sulphate, total antioxidant capacity, and total oxidant status in central serous chorioretinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 252, 17\u201321. https:\/\/doi.org\/10.1007\/s00417-013-2396-2 (2014).","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"71890_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2023.103281","volume":"7","author":"A Kumar","year":"2023","unstructured":"Kumar, A. et al. Association of serum vitamin d levels with clinical spectrum of central serous chorioretinopathy patients of indian origin. Photodiagnosis Photodyn. Ther. 7, 103281. https:\/\/doi.org\/10.1016\/j.pdpdt.2023.103281 (2023).","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"71890_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2022.805305","volume":"9","author":"Y Ji","year":"2022","unstructured":"Ji, Y. et al. Investigation of serum and macular carotenoids in central serous chorioretinopathy. Front. Med. (Lausanne) 9, 1\u20136. https:\/\/doi.org\/10.3389\/fmed.2022.805305 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"71890_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000455807","volume":"237","author":"A Shinojima","year":"2017","unstructured":"Shinojima, A. et al. A Multicenter randomized controlled study of antioxidant supplementation with lutein for chronic central serous chorioretinopathy. Ophthalmologica 237, 159\u2013166. https:\/\/doi.org\/10.1159\/000455807 (2017).","journal-title":"Ophthalmologica"},{"key":"71890_CR34","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.arcmed.2012.08.012","volume":"43","author":"MM Mehdi","year":"2012","unstructured":"Mehdi, M. M. et al. Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: Correlation with susceptibility of LDL oxidation. Arch. Med. Res. 43, 438\u2013443. https:\/\/doi.org\/10.1016\/j.arcmed.2012.08.012 (2012).","journal-title":"Arch. Med. Res."},{"key":"71890_CR35","doi-asserted-by":"publisher","first-page":"5624","DOI":"10.2174\/092986711798347216","volume":"18","author":"C Schrader","year":"2011","unstructured":"Schrader, C. et al. Determinants of paraoxonase 1 status: Genes, drugs and nutrition. Curr. Med. Chem. 18, 5624\u20135643. https:\/\/doi.org\/10.2174\/092986711798347216 (2011).","journal-title":"Curr. Med. Chem."},{"key":"71890_CR36","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.clinbiochem.2011.04.015","volume":"44","author":"N Yilmaz","year":"2011","unstructured":"Yilmaz, N. et al. Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin. Biochem. 44, 832\u2013837. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.04.015 (2011).","journal-title":"Clin. Biochem."},{"key":"71890_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2174\/1874091X01408010100","volume":"8","author":"E Eren","year":"2014","unstructured":"Eren, E. et al. Anticipatory role of high density lipoprotein and endothelial dysfunction: An overview. Open Biochem. J. 8, 100\u2013106. https:\/\/doi.org\/10.2174\/1874091X01408010100 (2014).","journal-title":"Open Biochem. J."},{"key":"71890_CR38","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/ped.12557","volume":"57","author":"A Annag\u00fcr","year":"2015","unstructured":"Annag\u00fcr, A. et al. Total antioxidant and total oxidant states, and serum paraoxonase-1 in neonatal sepsis. Pediatr. Int. 57, 608\u2013613. https:\/\/doi.org\/10.1111\/ped.12557 (2015).","journal-title":"Pediatr. Int."},{"key":"71890_CR39","doi-asserted-by":"publisher","first-page":"513","DOI":"10.4103\/ijmr.IJMR_1284_14","volume":"145","author":"SR Bharathidevi","year":"2017","unstructured":"Bharathidevi, S. R. et al. Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina. Indian J. Med. Res. 145, 513\u2013520. https:\/\/doi.org\/10.4103\/ijmr.IJMR_1284_14 (2017).","journal-title":"Indian J. Med. Res."},{"key":"71890_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12013-011-9221-5","volume":"61","author":"XL Jiang","year":"2011","unstructured":"Jiang, X. L. et al. Plasma paraoxonase-1, oxidized low-density lipoprotein and lipid peroxidation levels in gout patients. Cell Biochem. Biophys. 61, 461\u2013466. https:\/\/doi.org\/10.1007\/s12013-011-9221-5 (2011).","journal-title":"Cell Biochem. Biophys."},{"key":"71890_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25173855","volume":"25","author":"S Bassu","year":"2020","unstructured":"Bassu, S. et al. Oxidative stress biomarkers and peripheral endothelial dysfunction in rheumatoid arthritis: A monocentric cross-sectional case-control study. Molecules 25, 1\u201311. https:\/\/doi.org\/10.3390\/molecules25173855 (2020).","journal-title":"Molecules"},{"key":"71890_CR42","first-page":"2578","volume":"16","author":"A Javadzadeh","year":"2010","unstructured":"Javadzadeh, A. et al. Plasma oxidized LDL and thiol-containing molecules in patients with exudative age-related macular degeneration. Mol. Vis. 16, 2578\u20132584 (2010).","journal-title":"Mol. Vis."},{"key":"71890_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0002-9394(99)00075-6","volume":"128","author":"MK Tittl","year":"1999","unstructured":"Tittl, M. K. et al. Systemic findings associated with central serous chorioretinopathy. Am. J. Ophthalmol. 128, 63\u201368. https:\/\/doi.org\/10.1016\/s0002-9394(99)00075-6 (1999).","journal-title":"Am. J. Ophthalmol."},{"key":"71890_CR44","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","volume":"111","author":"R Haimovici","year":"2004","unstructured":"Haimovici, R. et al. Risk factors for central serous chorioretinopathy: A case-control study. Ophthalmology 111, 244\u2013249. https:\/\/doi.org\/10.1016\/j.ophtha.2003.09.024 (2004).","journal-title":"Ophthalmology"},{"key":"71890_CR45","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1136\/bjophthalmol-2012-301810","volume":"96","author":"D Tsai","year":"2012","unstructured":"Tsai, D. et al. Central serous chorioretinopathy and risk of ischaemic stroke: A population-based cohort study. Br. J. Ophthalmol. 96, 1484\u20131488. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-301810 (2012).","journal-title":"Br. J. Ophthalmol."},{"key":"71890_CR46","doi-asserted-by":"publisher","first-page":"899","DOI":"10.2147\/opth.s12583","volume":"4","author":"A Caccavale","year":"2010","unstructured":"Caccavale, A. et al. Low-dose aspirin as treatment for central serous chorioretinopathy. Clin. Ophthalmol. 4, 899\u2013903. https:\/\/doi.org\/10.2147\/opth.s12583 (2010).","journal-title":"Clin. Ophthalmol."},{"key":"71890_CR47","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s12529-017-9636-5","volume":"24","author":"BD Pollock","year":"2017","unstructured":"Pollock, B. D. et al. Associations between hunter type A\/B personality and cardiovascular risk factors from adolescence through young adulthood. Int. J. Behav. Med. 24, 593\u2013601. https:\/\/doi.org\/10.1007\/s12529-017-9636-5 (2017).","journal-title":"Int. J. Behav. Med."},{"key":"71890_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MD.0000000000014859","volume":"98","author":"Y Chang","year":"2019","unstructured":"Chang, Y. et al. Increased risk of central serous chorioretinopathy following end-stage renal disease: A nationwide population-based study. Medicine (Baltimore) 98, 1\u20137. https:\/\/doi.org\/10.1097\/MD.0000000000014859 (2019).","journal-title":"Medicine (Baltimore)"},{"key":"71890_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph16245099","volume":"16","author":"H Hsu","year":"2019","unstructured":"Hsu, H. et al. The correlation of central serous chorioretinopathy and subsequent cardiovascular diseases of different types: A population-based cohort study. Int. J. Environ. Res. Public Health 16, 1\u201310. https:\/\/doi.org\/10.3390\/ijerph16245099 (2019).","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71890-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71890-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T17:14:12Z","timestamp":1726247652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71890-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71890"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71890-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"15 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21099"}}